Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study
This study identified critical prognostic factors and developed a validated scoring system for estimating 5-year survival in patients with EGFR-mutated NSCLC receiving EGFR-TKIs. While the model demonstrated robust predictive performance within the study cohort, broader applicability beyond Taiwan may require further refinements and alternative study designs.
Authors
- I-Lin Tsai
- Qi‐An Wang (ORCID: https://orcid.org/0009-0008-7340-3405)
- Yueh‐Fu Fang (ORCID: https://orcid.org/0000-0003-2211-3076)
- Chih‐Hsi S. Kuo (ORCID: https://orcid.org/0000-0003-3309-937X)
- Ching‐Fu Chang (ORCID: https://orcid.org/0000-0001-5219-6357)
- Chenyang Huang (ORCID: https://orcid.org/0000-0002-1956-6229)
- Ping‐Chih Hsu (ORCID: https://orcid.org/0000-0003-0173-7509)
- Po‐Lan Su (ORCID: https://orcid.org/0000-0002-8470-6590)
- John Wen‐Cheng Chang (ORCID: https://orcid.org/0000-0001-8373-5691)
- Cheng-Ta Yang (ORCID: https://orcid.org/0000-0001-8256-2477)
- Chiao‐En Wu (ORCID: https://orcid.org/0000-0002-1081-8805)
- Chien‐Chung Lin (ORCID: https://orcid.org/0000-0002-4739-5631)
- Chien‐Yu Lin
Institutions
- Chang Gung University (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251321901
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Chang Gung Memorial Hospital, Linkou